Home Medicine Remission of congenital hyperinsulinism following conservative treatment: an exploratory study in patients with KATP channel mutations
Article
Licensed
Unlicensed Requires Authentication

Remission of congenital hyperinsulinism following conservative treatment: an exploratory study in patients with KATP channel mutations

  • Mark J. Lachmann , Burak Salgin , Sebastian Kummer , Alena Welters , Carsten Döing , Martin Zenker , Ilse Wieland , Ertan Mayatepek and Thomas Meissner EMAIL logo
Published/Copyright: November 18, 2015

Abstract

Background: During conservative treatment, congenital hyperinsulinism (CHI) can resolve spontaneously. This study describes the hormonal and metabolic profiles in three patients with ABCC8/KCNJ11 mutations in clinical remission.

Methods: An age-adapted fasting and oral glucose tolerance test (OGTT) were performed.

Results: All patients (aged 6–9 years) tolerated age-adapted fasting durations (20, respectively 24 h), without reaching glucose concentrations ≤2.5 mmol/L, nor developing hypoglycemia-related symptoms. Nevertheless, insulin concentrations from all patients exceeded the 90th reference percentile at the end of the fasting test (range: 4.2–15.8 mU/L). During the OGTT, one patient (patient 2; BMI: 23.4 kg/m2; age: 7 years) reached a glucose concentration of 11.4 mmol/L after 2 h (concomitant insulin concentration: 148.3 mU/L).

Conclusions: The insulin concentration profiles in CHI patients in apparent clinical remission range from almost complete normalization to persistent, yet attenuated, hypersecretion. The hyperglycemia, detected during the OGTT, must be further monitored.


Corresponding author: Thomas Meissner, MD, Department of General Pediatrics, Neonatology and Pediatric Cardiology, University Children’s Hospital Düsseldorf, Moorenstr. 5, 40225 Düsseldorf, Germany, Phone: +49-211-8117384, Fax: +49-211-8119512, E-mail:

References

1. Meissner T, Beinbrech B, Mayatepek E. Congenital hyperinsulinism: molecular basis of a heterogeneous disease. Hum Mutat 1999;13:351–61.10.1002/(SICI)1098-1004(1999)13:5<351::AID-HUMU3>3.0.CO;2-RSearch in Google Scholar

2. Stanley CA. Hyperinsulinism in infants and children. Pediatr Clin North Am 1997;44:363–74.10.1016/S0031-3955(05)70481-8Search in Google Scholar

3. Arnoux J-B, Verkarre V, Saint-Martin C, Montravers F, Brassier A, et al. Congenital hyperinsulinism: current trends in diagnosis and therapy. Orphanet J Rare Dis 2011;6:63.10.1186/1750-1172-6-63Search in Google Scholar

4. Yorifuji T. Congenital hyperinsulinism: current status and future perspectives. Ann Pediatr Endocrinol Metab 2014;19:57–68.10.6065/apem.2014.19.2.57Search in Google Scholar

5. Bruining G. Recent advances in hyperinsulinism and the pathogenesis of diabetes mellitus. Curr Opin Pediatr 1990;2:758–65.10.1097/00008480-199008000-00024Search in Google Scholar

6. De León DD, Stanley CA. Mechanisms of disease: advances in diagnosis and treatment of hyperinsulinism in neonates. Nat Clin Pract Endocrinol Metab 2007;3:57–68.10.1038/ncpendmet0368Search in Google Scholar

7. Nestorowicz A, Wilson BA, Schoor KP, Inoue H, Glaser B, et al. Mutations in the sulonylurea receptor gene are associated with familial hyperinsulinism in Ashkenazi Jews. Hum Mol Genet 1996;5:1813–22.10.1093/hmg/5.11.1813Search in Google Scholar

8. Nestorowicz A, Inagaki N, Gonoi T, Schoor KP, Wilson BA, et al. A nonsense mutation in the inward rectifier potassium channel gene, Kir6.2, is associated with familial hyperinsulinism. Diabetes 1997;46:1743–8.10.2337/diab.46.11.1743Search in Google Scholar

9. Giurgea I, Bellanné-Chantelot C, Ribeiro M, Hubert L, Sempoux C, et al. Molecular mechanisms of neonatal hyperinsulinism. Horm Res 2006;66:289–96.10.1159/000095938Search in Google Scholar

10. Stanley CA, Baker L. Hyperinsulinism in infancy: diagnosis by demonstration of abnormal response to fasting hypoglycemia. Pediatrics 1976;57:702–11.10.1542/peds.57.5.702Search in Google Scholar

11. Aynsley-Green A, Hussain K, Hall J, Saudubray JM, Nihoul-Fékété C, et al. Practical management of hyperinsulinism in infancy. Arch Dis Child Fetal Neonatal Ed 2000;82:F98–107.10.1136/fn.82.2.F98Search in Google Scholar

12. Meissner T, Wendel U, Burgard P, Schaetzle S, Mayatepek E. Long-term follow-up of 114 patients with congenital hyperinsulinism. Eur J Endocrinol 2003;149:43–51.10.1530/eje.0.1490043Search in Google Scholar PubMed

13. Leibowitz G, Glaser B, Higazi AA, Salameh M, Cerasi E, et al. Hyperinsulinemic hypoglycemia of infancy (nesidioblastosis) in clinical remission: high incidence of diabetes mellitus and persistent beta-cell dysfunction at long-term follow-up. J Clin Endocrinol Metab 1995;80:386–92.Search in Google Scholar

14. Arya VB, Senniappan S, Demirbilek H, Alam S, Flanagan SE, et al. Pancreatic endocrine and exocrine function in children following near-total pancreatectomy for diffuse congenital hyperinsulinism. PLoS ONE 2014;9:e98054.10.1371/journal.pone.0098054Search in Google Scholar PubMed PubMed Central

15. Beltrand J, Caquard M, Arnoux J-B, Laborde K, Velho G, et al. Glucose metabolism in 105 children and adolescents after pancreatectomy for congenital hyperinsulinism. Diabetes Care 2012;35:198–203.10.2337/dc11-1296Search in Google Scholar PubMed PubMed Central

16. Mazor-Aronovitch K, Gillis D, Lobel D, Hirsch HJ, Pinhas-Hamiel O, et al. Long-term neurodevelopmental outcome in conservatively treated congenital hyperinsulinism. Eur J Endocrinol 2007;157:491–7.10.1530/EJE-07-0445Search in Google Scholar PubMed

17. Glaser B, Ryan F, Donath M, Landau H, Stanley CA, et al. Hyperinsulinism caused by paternal-specific inheritance of a recessive mutation in the sulfonylurea-receptor gene. Diabetes 1999;48:1652–7.10.2337/diabetes.48.8.1652Search in Google Scholar PubMed

18. Banerjee I, Skae M, Flanagan SE, Rigby L, Patel L, et al. The contribution of rapid KATP channel gene mutation analysis to the clinical management of children with congenital hyperinsulinism. Eur J Endocrinol 2011;164:733–40.10.1530/EJE-10-1136Search in Google Scholar PubMed

19. Kumaran A, Kapoor RR, Flanagan SE, Ellard S, Hussain K. Congenital hyperinsulinism due to a compound heterozygous ABCC8 mutation with spontaneous resolution at eight weeks. Horm Res Paediatr 2010;73:287–92.10.1159/000284394Search in Google Scholar PubMed

20. Abdulhadi-Atwan M, Bushman J, Bushmann J, Tornovsky-Babaey S, Perry A, et al. Novel de novo mutation in sulfonylurea receptor 1 presenting as hyperinsulinism in infancy followed by overt diabetes in early adolescence. Diabetes 2008;57:1935–40.10.2337/db08-0159Search in Google Scholar PubMed PubMed Central

21. Gussinyer M, Clemente M, Cebrián R, Yeste D, Albisu M, et al. Glucose intolerance and diabetes are observed in the long-term follow-up of nonpancreatectomized patients with persistent hyperinsulinemic hypoglycemia of infancy due to mutations in the ABCC8 gene. Diabetes Care 2008;31:1257–9.10.2337/dc07-2059Search in Google Scholar PubMed

22. Finegold DN, Stanley CA, Baker L. Glycemic response to glucagon during fasting hypoglycemia: an aid in the diagnosis of hyperinsulinism. J Pediatr 1980;96:257–9.10.1016/S0022-3476(80)80817-1Search in Google Scholar

23. Van Veen MR, van Hasselt PM, de Sain-van der Velden MG, Verhoeven N, Hofstede FC, et al. Metabolic profiles in children during fasting. Pediatrics 2011;127:e1021–7.10.1542/peds.2010-1706Search in Google Scholar

24. Guthrie RA, Guthrie DW, Murthy DY, Jackson RL, Lang J. Standardization of the oral glucose tolerance test and the criteria for diagnosis of chemical diabetes in children. Metabolism 1973;22:275–82.10.1016/0026-0495(73)90172-8Search in Google Scholar

25. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2012;35(Suppl 1):S64–71.10.2337/dc12-s064Search in Google Scholar

26. Yorifuji T, Hosokawa Y, Fujimaru R, Kawakita R, Doi H, et al. Lasting 18F-DOPA PET uptake after clinical remission of the focal form of congenital hyperinsulinism. Horm Res Paediatr 2011;76:286–90.10.1159/000328056Search in Google Scholar

27. Kassem SA, Ariel I, Thornton PS, Scheimberg I, Glaser B. Beta-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. Diabetes 2000;49:1325–33.10.2337/diabetes.49.8.1325Search in Google Scholar

28. Grimberg A, Ferry RJ, Kelly A, Koo-McCoy S, Polonsky K, et al. Dysregulation of insulin secretion in children with congenital hyperinsulinism due to sulfonylurea receptor mutations. Diabetes 2001;50:322–8.10.2337/diabetes.50.2.322Search in Google Scholar

29. Harel S, Cohen AS, Hussain K, Flanagan SE, Schlade-Bartusiak K, et al. Alternating hypoglycemia and hyperglycemia in a toddler with a homozygous p.R1419H ABCC8 mutation: an unusual clinical picture. J Pediatr Endocrinol Metab 2015;28:345–51.Search in Google Scholar

30. Mohnike K, Wieland I, Barthlen W, Vogelgesang S, Empting S, et al. Clinical and genetic evaluation of patients with KATP channel mutations from the German registry for congenital hyperinsulinism. Horm Res Paediatr 2014;81:156–68.10.1159/000356905Search in Google Scholar

31. Glaser B. Dominant SUR1 mutation causing autosomal dominant type 2 diabetes. Lancet 2003;361:272–3.10.1016/S0140-6736(03)12363-XSearch in Google Scholar

Received: 2015-5-12
Accepted: 2015-9-25
Published Online: 2015-11-18
Published in Print: 2016-3-1

©2016 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Review
  3. Role of nutrition in preventing insulin resistance in children
  4. Original Articles
  5. Reduced frequency and severity of ketoacidosis at diagnosis of childhood type 1 diabetes in Northwest Saudi Arabia
  6. Differences in parental involvement in the care of children and adolescents with type 1 diabetes mellitus on multiple daily insulin injections versus continuous subcutaneous insulin infusion
  7. Value of the intrarenal arterial resistivity indices and different renal biomarkers for early identification of diabetic nephropathy in type 1 diabetic patients
  8. Remission of congenital hyperinsulinism following conservative treatment: an exploratory study in patients with KATP channel mutations
  9. Relationship between visceral obesity and plasma fibrinogen in obese children
  10. Diagnostic approach in children with unusual symptoms of acquired hypothyroidism. When to look for pituitary hyperplasia?
  11. The shortened combined clonidine and arginine test for growth hormone deficiency is practical and specific: a diagnostic accuracy study
  12. Bone maturation along the spectrum from normal weight to obesity: a complex interplay of sex, growth factors and weight gain
  13. Outcomes analysis of radioactive iodine and total thyroidectomy for pediatric Graves’ disease
  14. Direct sequencing of FAH gene in Pakistani tyrosinemia type 1 families reveals a novel mutation
  15. Odontoiatric perspectives and osteonecrosis of the jaw as a possible adverse effect of bisphosphonates therapy in fibrous dysplasia and McCune-Albright syndrome
  16. The relation of urinary bisphenol A with kisspeptin in girls diagnosed with central precocious puberty and premature thelarche
  17. Pattern of teen menstruation among secondary school girls in south east Nigeria
  18. Should children with isolated premature adrenarche be routinely evaluated for non-classical congenital adrenal hyperplasia?
  19. Anxiety, depression and self-esteem levels in obese children: a case-control study
  20. Case Reports
  21. Transient congenital hypothyroidism caused by compound heterozygous mutations affecting the NADPH-oxidase domain of DUOX2
  22. Isolated methylmalonic acidemia with unusual presentation mimicking diabetic ketoacidosis
  23. A first case report of UDP-galactose-4′-epimerase deficiency in China: genotype and phenotype
  24. A novel mutation in the glutamate dehydrogenase (GLUD1) of a patient with congenital hyperinsulinism-hyperammonemia (HI/HA)
  25. Letter to the Editor
  26. Partial biotinidase deficiency: identification of a single novel mutation (p.H314R) in a Greek newborn
Downloaded on 18.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2015-0192/pdf
Scroll to top button